2026 NPPES data Internal Medicine Physician NPI 1801044839 MD
Verify on CMS →

AFROUZ GERAYLI, MD

Internal Medicine Physician in CAMARILLO, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
15K
Medicare Part D claims · 855 beneficiaries · Internal Medicine Physician avg: 3K
Generic prescribing
85%
generic claims · 15% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
79.268/100
▼ 4 pts below national avg 83.1 · [object Object]
Industry payments
$1.5K
55 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

AFROUZ GERAYLI, MD reported a CMS MIPS final score of 79.268/100 — below the 83.1 national average — and filed 14,945 Medicare Part D claims in 2023.

79.268/100
MIPS score · -4 vs avg
15K
Part D claims, 2023
85%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

AFROUZ GERAYLI, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

79 30th percentile higher than 30% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

AFROUZ GERAYLI, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about AFROUZ GERAYLI, MD?

Near national average

NPI registry status

Active

Issued 09/03/2008

NPI 1801044839

Primary specialty

Internal Medicine Physician

High-volume

172,858 US NPIs in this specialty

Medicare Part D claims

14,945 450% vs specialty avg

2023 prescription claims

Specialty avg: 2,716

MIPS final score

79.268/100 3.8319999999999936% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in California

How Internal Medicine Physician compares to other specialties among California providers

California providers

Internal Medicine Physician share within California

1. Internal Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Internal Medicine Physician share within California

Medicare quality performance — MIPS

AFROUZ GERAYLI, MD's 2023 MIPS final score plotted against the Internal Medicine Physician national average

Near national average
MIPS Final Score
79.268/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Internal Medicine Physician) — 79.268/100 vs national avg 83.1

0%100%National avg83%79.3%
MIPS final score (Internal Medicine Physician) — 79.268/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

AFROUZ GERAYLI, MD appears in the CMS NPPES registry as a Internal Medicine Physician provider holding MD credentials at 500 PASEO CAMARILLO, CAMARILLO, CA, 93010, with a listed phone of (805) 484-1033. NPI 1801044839 was issued on 09/03/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GERAYLI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 14,945 prescription claims written by this provider, covering 855 Medicare beneficiaries and totaling roughly $2.0 million in drug spend, split 15% brand-name and 85% generic by claim count, with an opioid prescribing rate of 1.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 79.268/100 for the 2023 performance year (Quality 98.1182, Cost 33.4023), compared with the national average of 83.1.

Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

500 PASEO CAMARILLO
CAMARILLO, CA 93010

Provider Details

NPI 1801044839
Specialty Internal Medicine Physician
Credentials MD
Gender Female
NPI Issued 09/03/2008

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

79.268
Final Score
Avg: 83.1
98.1182
Quality
33.4023
Cost

Reporting: Individual

Hospital and facility affiliations

Facilities where AFROUZ GERAYLI, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

AFROUZ GERAYLI MD INC
CAMARILLO, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for AFROUZ GERAYLI, MD. Source: openpaymentsdata.cms.gov.

Total received

$1.5K

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to AFROUZ GERAYLI, MD. To verify AFROUZ GERAYLI, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

AFROUZ GERAYLI, MD — brand share 15.0%
Specialty average (est.)

15% brand-name claims vs 85% generic, on 14,945 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

14,945
Total Claims
$2.0M
Total Drug Cost
855
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
30,785
Total Day Supply
895,621
Brand vs Generic
15% brand / 85% generic
Brand Drug Cost
$1.7M
Generic Drug Cost
$317K
Opioid Claims
208 (1.4% rate)
Antibiotic Claims
401

Patient Demographics

Average Patient Age
77.5 years
Avg HCC Risk Score
1.15
Gender Split
67% female / 33% male
Age Distribution
<65: 31, 65-74: 293, 75-84: 328, 85+: 203

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What AFROUZ GERAYLI, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Amlodipine Besylate
857
Levothyroxine Sodium
778
Rosuvastatin Calcium
776
Atorvastatin Calcium
515
Olmesartan Medoxomil
400
Valsartan
399
Metformin Hcl
394
Metoprolol Succinate
337
Pantoprazole Sodium
335
Omeprazole
324

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Internal Medicine Physician Overview

How AFROUZ GERAYLI, MD fits within the Internal Medicine Physician landscape nationally.

172,858
Internal Medicine Physician Providers in US
56
States with Internal Medicine Physician
2,716
Avg Claims per Provider

AFROUZ GERAYLI, MD's 14,945 claims are above the specialty average of 2,716.

Nearby Internal Medicine Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as GERAYLI.

Compare Internal Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is AFROUZ GERAYLI, MD's specialty?
AFROUZ GERAYLI, MD specializes in Internal Medicine Physician and practices in CAMARILLO, California. Credentials: MD.
How much does AFROUZ GERAYLI, MD prescribe under Medicare Part D?
In 2023, AFROUZ GERAYLI, MD wrote 14,945 Medicare Part D claims totaling $2.0M in drug costs for 855 beneficiaries.
What is AFROUZ GERAYLI, MD's Medicare quality score?
AFROUZ GERAYLI, MD has a CMS MIPS Final Score of 79.268/100 (Quality: 98.1182, Cost: 33.4023). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is AFROUZ GERAYLI, MD located?
AFROUZ GERAYLI, MD is located at 500 PASEO CAMARILLO, CAMARILLO, CA, 93010. Phone: (805) 484-1033.
What is AFROUZ GERAYLI, MD's NPI number?
AFROUZ GERAYLI, MD's National Provider Identifier (NPI) is 1801044839, issued on 09/03/2008.
Does AFROUZ GERAYLI, MD prescribe more brand-name or generic drugs?
AFROUZ GERAYLI, MD's prescribing is 15% brand-name and 85% generic drugs by claim count, with $1.7M in brand drug costs.
Does AFROUZ GERAYLI, MD prescribe opioids?
Yes, AFROUZ GERAYLI, MD had 208 opioid claims in 2023 with an opioid prescribing rate of 1.4%.
How many Internal Medicine Physician providers are there in the US?
There are 172,858 Internal Medicine Physician providers across 56 states in the US. The average Internal Medicine Physician provider writes 2,716 Medicare Part D claims per year.
What drugs does AFROUZ GERAYLI, MD prescribe most often?
Based on 2023 Medicare Part D data, AFROUZ GERAYLI, MD's most frequently prescribed drugs include Amlodipine Besylate, Levothyroxine Sodium, Rosuvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does AFROUZ GERAYLI, MD accept Medicare?
AFROUZ GERAYLI, MD appears in CMS Medicare data with 14,945 Part D claims and 855 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify AFROUZ GERAYLI, MD's credentials?
AFROUZ GERAYLI, MD's NPI is 1801044839 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology